Recent Finacing
Recent Raise
PharmNovo is a clinical-stage pharmaceutical company based in Lund, Sweden, developing PN6047, a selective neuropathic pain drug candidate originating from AstraZeneca research and advancing through Phase 1/2 clinical trials.
